Bioventus (BVS) Times Interest Earned (2020 - 2021)
Bioventus' (BVS) quarterly Times Interest Earned came in at 52.5 in Q2 2021, down 66.45% on a YoY basis from 156.49 in Q2 2020, and down 66.45% quarter-over-quarter from 156.49 in Q1 2020.
Powered by 
Analysis
Bioventus (BVS) Times Interest Earned (2020 - 2021) Analysis & Trends
Bioventus (BVS) has reported Times Interest Earned for 2 consecutive years, with 52.5 the latest figure, recorded in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 4.82 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.48 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 11.77 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.27 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.21 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.09 |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | - |